Mantis Health — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Mantis Health is an early-stage, private medical device company founded in 2021, headquartered in Stamford, CT (with a noted San Francisco connection in provided data). The company has developed a digital surgical visualization system designed to disrupt the traditional surgical microscope market. Its platform combines lightweight 3D glasses, a compact overhead 3D camera, and AI integration to offer surgeons superior ergonomics, faster setup, and significant cost savings. Mantis positions its technology as a next-generation tool for magnified micro-surgery across various specialties.

Surgical VisualizationMicrosurgery

Technology Platform

A digital surgical visualization platform comprising lightweight 3D display glasses and a compact overhead 3D camera station. The system delivers real-time, high-resolution stereoscopic video with digital zoom, focus, and pan controls, enabling ergonomic surgery, external display, procedure recording, and AI integration.

Opportunities

The primary opportunity is displacing expensive, bulky traditional surgical microscopes in hospitals and ASCs globally by offering a superior ergonomic, cost-effective, and digitally-native alternative.

The platform also creates a foundation for high-margin software and AI services, such as procedural analytics and guided surgery tools, transforming a capital equipment sale into a recurring revenue model.

Risk Factors

Key risks include regulatory hurdles for a novel medical device, resistance to adoption from surgeons accustomed to traditional microscopes, and potential competition from large, established medtech companies with greater resources.

Execution risks in manufacturing, supply chain, and achieving reliable clinical performance are also significant for an early-stage hardware startup.

Competitive Landscape

Mantis competes directly with high-end surgical microscope manufacturers like Carl Zeiss Meditec, Leica Microsystems, and Haag-Streit Surgical. It also competes with digital visualization systems from companies like Sony and Vuzix, and with traditional optical loupes. Its key differentiators are the combination of true 3D, lightweight glasses-form factor, and a low total system cost.

More companies in Digital Health & Biotech SaaS →More companies in United States →